Episode 291: Psychedelics for Chronic Pa...

In this 315th episode I welcome Drs. Jon Tang, Jordan Halloway and Manoj Iyer to the show to discuss the latest updates on leadless pacemakers and ICDs.Our Sponsors:* Check out Eko: https://ekohealth.com/ACCRAC* Check out FIGS and use my code FIGSRX for a great deal: https://wear ... Show More

In this 314th episode I welcome Thomas Piraino and Brandon Oto to the show to discuss how we can optimize PEEP in the ICU. We talk about why it matters, different ways to estimate ideal PEEP, and what the research tells us. Our Sponsors:* Check out Eko: https://ekohealth.com/ACCR ... Show More

In this 313th episode I welcome Dr. Alexis Motz to the show as she finishes her residency in anesthesiology. We discuss the lessons she learned along the way about how to get the most out of the experience and be the best resident, and all around physician, possible. We also disc ... Show More

What do the clinical trials of psilocybin and other psychedelics show in terms of efficacy and safety? How much of the benefit with psychedelic treatment is attributable to psychological support? Is the psychedelic trip important for the therapeutic benefits of psychedelic treatm ... Show More

What if the key to healing depression isn’t another pill but a profound shift in consciousness? On this episode of The Dr. Hyman Show, I talk with Dr. Robin Carhart-Harris, one of the world’s leading psychedelic researchers, about how these compounds unlock plasticity in the brai ... Show More

Send us a textIn today’s episode of the Psychedelic Therapy Frontiers podcast, Dr. Steve Thayer and Dr. Reid Robison discuss attachment styles and how psychedelic therapy might be used to address issues related to attachment wounding. *This episode originally aired 5/16/23Learn m ... Show More

Send us a textThe path to FDA approved prescribable medicine has been a long and precarious one for psychedelics. However, recent reports by some of the major players in the psychedelic medicine space show promising results from clinical trials involving psilocybin and 5-MeO-DMT. ... Show More

Send us a textIn this episode of the Psychedelic Therapy Frontiers podcast Dr. Steve Thayer and Dr. Reid Robison explore how psychedelic experiences might solicit false or maladaptive beliefs. Learn more about our podcast at https://numinusnetwork.com/learn/podcast/ Learn more ab ... Show More

It's time to make psychiatry more psychedelic, says psychiatrist Benjamin Lewis. Sharing results from his clinical trial on psychedelic-assisted therapy, he highlights how group therapy paired with the safe use of psilocybin, a compound found in magic mushrooms, has the potential ... Show More

In this episode, Ben Malcolm (the Spirit Pharmacist) brings us into the intersection of psychedelics and pharmacology. We discuss practical considerations, such as guidelines for safely tapering off SSRIs before embarking on a psychedelic experience and navigating contraindicatio ... Show More

In this episode, we discuss our article of the week from JAMA Network Open which is entitled “Patient complexity, social factors, and hospitalization outcomes at academic and community hospitals.” Then, we discuss the positive relief on pain and anxiety that immersive imagery and ... Show More

In this Huberman Lab Essentials episode, my guest is Dr. Matthew Johnson, PhD, a senior researcher for the Center of Excellence for Psilocybin Research and Treatment at Sheppard Pratt’s Institute for Advanced Diagnostics and Therapeutics. We explore the science and therapeutic po ... Show More

Today Dr. K talks about the relationships between pessimistic thoughts and depression, identity and ego, and more! Support this podcast at — https://redcircle.com/healthygamergg/donations Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com ... Show More